|
|
|
|
news.yahoo.com
--
2 hours, 47 minutes ago (Reuters) - Amgen Inc (AMGN.O) is halting some pricing practices that critics say were contributing to overuse of its flagship anemia drug Aranesp at a time of mounting concerns about the product's safety, the New York Times said..
Read More
|
|
|
biz.yahoo.com
--
WASHINGTON--(BUSINESS WIRE)--Citizens Against Government Waste (CAGW) today released its preliminary analysis of the Senate version of the Fiscal 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Act. There are 287 pr..
Read More
|
|
|
biz.yahoo.com
--
A buyout offer from King Pharmaceuticals for fellow drug maker Alpharma resuscitated pharmaceutical ETFs at the end of an otherwise dull week of trading.
Alpharma (NYSE:ALO - News)shares gapped up 10.47, or 44%, to 34.51 in monstrous volume. The pain dru..
Read More
|
|
|
biz.yahoo.com
--
WASHINGTON (AP) -- Nearly three years into the Medicare drug benefit, federal officials have yet to ensure that private drug plans enacted programs to deter fraud and abuse, government investigators say.
About 24 million people are enrolled in Medicare d..
Read More
|
|
|
biz.yahoo.com
--
INDIANAPOLIS, Ind., Aug. 20 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY - News) today announced that it has completed the acquisition of SGX Pharmaceuticals, Inc. (Nasdaq: SGXP - News), a San Diego-based biotechnology company focused on dru..
Read More
|
|
|
biz.yahoo.com
--
WASHINGTON (AP) -- CVS Caremark Corp., the nation's largest pharmacy chain, spent just over $1 million in the second quarter to lobby the federal government, according to a recent disclosure form.
The Woonsocket, R.I.-based company lobbied on legislation..
Read More
|
|
|
biz.yahoo.com
--
PITTSBURGH (AP) -- Generic drug maker Mylan Inc. said Wednesday it swung to a loss after buying the generics unit of German drug maker Merck KGaA, although the acquisition allowed Mylan to more than double its second-quarter revenue.
Mylan took a loss of..
Read More
|
|
|
biz.yahoo.com
--
INDIANAPOLIS, Aug. 6 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY - News) today announced that Covance Inc. (NYSE: CVD - News), one of the world's leading drug development services companies, will buy and operate Lilly's Greenfield Laborator..
Read More
|
|
|
biz.yahoo.com
--
NEW YORK (AP) -- ImClone Systems Inc.'s board of directors said Monday cancer drug partner Bristol-Myers Squibb Co.'s $4.5 billion buyout offer "substantially undervalues" the company, with Chairman Carl Icahn personally against the deal.
Despite calling..
Read More
|
|
|
biz.yahoo.com
--
WASHINGTON (AP) -- Drug and medical device maker Abbott Laboratories spent just over $1 million lobbying the federal government on health care issues in the second quarter, according to a recent disclosure form.
Abbott lobbied against a bill aimed at upd..
Read More
|
|
|
biz.yahoo.com
--
TRENTON, N.J. (AP) -- Drugmaker Bristol-Myers Squibb Co. said Friday it has completed the sale of its high-tech dressing and wound-care business, which will free up money needed to buy the company's cancer drug partner, ImClone Systems Inc.
New York-base..
Read More
|
|
|
news.yahoo.com
--
By Bill Berkrot 15 minutes ago NEW YORK (Reuters) - Amgen Inc (AMGN.O) reported a far better-than-expected quarterly profit on a surprising rebound in sales of its anemia drug Aranesp from the preceding quarter, and the company raised its 2008 forecast...
Read More
|
|
|
news.yahoo.com
--
By Ransdell Pierson 9 minutes ago NEW YORK (Reuters) - Bristol-Myers Squibb Co (BMY.N), which sells leading blood clot preventer Plavix, on Thursday dismissed Eli Lilly and Co's (LLY.N) rival Effient drug as a "niche" product that has harmed or failed t..
Read More
|
|
|
news.yahoo.com
--
By Ransdell Pierson 4 minutes ago NEW YORK (Reuters) - Pfizer Inc (PFE.N) on Wednesday said quarterly earnings more than doubled on higher sales of its prescription drugs and lower expenses, but its Chantix quit-smoking drug lost more than a third of it..
Read More
|
|
|
biz.yahoo.com
--
DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/f9a13c/czech_republic_pha) has announced the addition of the "Czech Republic Pharmaceuticals and Healthcare Report Q3 2008" report to their offering.
This..
Read More
|
|
|
rss.cnn.com
--
Plastic bottle worriesMore VideosNEW YORK (AP) -- Israeli drugmaker Teva Pharmaceutical said Friday it will buy rival generic drug company Barr Pharmaceuticals for more than $7 billion in a move to expand its presence in U.S. and Eastern European markets...
Read More
|
|
|
biz.yahoo.com
--
NEW YORK (AP) -- ViroPharma Inc. shares wavered Wednesday as Wall Street took a second look at the company's buyout of Lev Pharmaceuticals and Lev's drug candidate Cinryze.
ViroPharma agreed to buy Lev on Tuesday for $442.9 million in cash and stock. If..
Read More
|
|
|
biz.yahoo.com
--
MUMBAI (Reuters) - The U.S. Food and Drug Administration has filed a motion in a U.S. court seeking documents from Indian drugmaker Ranbaxy Laboratories Ltd (Bombay:RANB.BO - News) as part of an ongoing investigation, a Ranbaxy spokesman said on Sunday...
Read More
|
|
|
money.cnn.com
--
FRANKFURT, Germany (AP) -- Fresenius SE said Monday it has agreed to buy U.S. generic drug maker APP Pharmaceuticals for $3.7 billion in cash in a deal that will give the German health care company more opportunities in the North American market for drugs..
Read More
|
|
|
news.yahoo.com
--
By Kim Dixon 1 hour, 13 minutes ago WASHINGTON (Reuters) - Chain drug stores including Walgreens (WAG.N) and pharmacy benefits managers like Medco Health Solutions (MHS.N) are combining their electronic networks to speed adoption of computerized prescri..
Read More
|
|
